CN111281914A - Traditional Chinese medicine composition for treating pneumonia - Google Patents
Traditional Chinese medicine composition for treating pneumonia Download PDFInfo
- Publication number
- CN111281914A CN111281914A CN202010094608.0A CN202010094608A CN111281914A CN 111281914 A CN111281914 A CN 111281914A CN 202010094608 A CN202010094608 A CN 202010094608A CN 111281914 A CN111281914 A CN 111281914A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- treating pneumonia
- chinese medicine
- medicine composition
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000003814 drug Substances 0.000 title claims abstract description 61
- 206010035664 Pneumonia Diseases 0.000 title claims abstract description 59
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 35
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 30
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 30
- 235000011477 liquorice Nutrition 0.000 claims abstract description 29
- 239000000843 powder Substances 0.000 claims description 36
- 239000002775 capsule Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 19
- 239000003826 tablet Substances 0.000 claims description 19
- 208000024891 symptom Diseases 0.000 claims description 8
- 241000711573 Coronaviridae Species 0.000 claims description 7
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 5
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 5
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 5
- 235000016357 Mirtillo rosso Nutrition 0.000 claims description 5
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims description 5
- 244000077923 Vaccinium vitis idaea Species 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 208000015181 infectious disease Diseases 0.000 claims description 5
- 241000205585 Aquilegia canadensis Species 0.000 claims description 4
- 241000209035 Ilex Species 0.000 claims description 4
- 235000003332 Ilex aquifolium Nutrition 0.000 claims description 4
- 235000002296 Ilex sandwicensis Nutrition 0.000 claims description 4
- 235000002294 Ilex volkensiana Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 240000005373 Panax quinquefolius Species 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 230000009385 viral infection Effects 0.000 claims description 4
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 3
- 244000105624 Arachis hypogaea Species 0.000 claims description 3
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 3
- 235000018262 Arachis monticola Nutrition 0.000 claims description 3
- 235000000832 Ayote Nutrition 0.000 claims description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 3
- 235000002767 Daucus carota Nutrition 0.000 claims description 3
- 244000000626 Daucus carota Species 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 240000000691 Houttuynia cordata Species 0.000 claims description 3
- 235000011430 Malus pumila Nutrition 0.000 claims description 3
- 244000070406 Malus silvestris Species 0.000 claims description 3
- 235000015103 Malus silvestris Nutrition 0.000 claims description 3
- 240000002624 Mespilus germanica Species 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 235000009811 Momordica charantia Nutrition 0.000 claims description 3
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 3
- 244000042430 Rhodiola rosea Species 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 208000036142 Viral infection Diseases 0.000 claims description 3
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 3
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 3
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 235000007215 black sesame Nutrition 0.000 claims description 3
- 235000021014 blueberries Nutrition 0.000 claims description 3
- 235000020971 citrus fruits Nutrition 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 229940087559 grape seed Drugs 0.000 claims description 3
- 235000020232 peanut Nutrition 0.000 claims description 3
- 235000015136 pumpkin Nutrition 0.000 claims description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 2
- 241000712892 Arenaviridae Species 0.000 claims description 2
- 241000758794 Asarum Species 0.000 claims description 2
- 241000007126 Codonopsis pilosula Species 0.000 claims description 2
- 241000711950 Filoviridae Species 0.000 claims description 2
- 241000710781 Flaviviridae Species 0.000 claims description 2
- 240000006927 Foeniculum vulgare Species 0.000 claims description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims description 2
- 241000605372 Fritillaria Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000013717 Houttuynia Nutrition 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims description 2
- 235000009496 Juglans regia Nutrition 0.000 claims description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 2
- 235000018365 Momordica dioica Nutrition 0.000 claims description 2
- 240000009023 Myrrhis odorata Species 0.000 claims description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 2
- 241000711504 Paramyxoviridae Species 0.000 claims description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 2
- 241001522129 Pinellia Species 0.000 claims description 2
- 241000405414 Rehmannia Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 229940116229 borneol Drugs 0.000 claims description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 230000036541 health Effects 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims description 2
- 239000012730 sustained-release form Substances 0.000 claims description 2
- 235000020234 walnut Nutrition 0.000 claims description 2
- 240000004244 Cucurbita moschata Species 0.000 claims 1
- 240000001740 Momordica dioica Species 0.000 claims 1
- 208000001528 Coronaviridae Infections Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 34
- 238000001035 drying Methods 0.000 description 23
- SPPIIOPGDLITJE-VLQRKCJKSA-N diazanium;(2s,3s,4s,5r,6s)-6-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-5-[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3,4-dihy Chemical compound N.N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O SPPIIOPGDLITJE-VLQRKCJKSA-N 0.000 description 21
- 206010011224 Cough Diseases 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 206010037660 Pyrexia Diseases 0.000 description 17
- 235000019359 magnesium stearate Nutrition 0.000 description 17
- 230000036760 body temperature Effects 0.000 description 16
- 230000008569 process Effects 0.000 description 15
- 230000036528 appetite Effects 0.000 description 13
- 235000019789 appetite Nutrition 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 12
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 11
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 11
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 11
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 11
- 235000005493 rutin Nutrition 0.000 description 11
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 11
- 229960004555 rutoside Drugs 0.000 description 11
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 6
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 6
- 229960003720 enoxolone Drugs 0.000 description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 6
- 229960004949 glycyrrhizic acid Drugs 0.000 description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 6
- 239000001685 glycyrrhizic acid Substances 0.000 description 6
- 235000019410 glycyrrhizin Nutrition 0.000 description 6
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 6
- 229960003752 oseltamivir Drugs 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229960003376 levofloxacin Drugs 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 229940072651 tylenol Drugs 0.000 description 4
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 3
- 229960003022 amoxicillin Drugs 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 229960004099 azithromycin Drugs 0.000 description 3
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 244000302512 Momordica charantia Species 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003470 adrenal cortex hormone Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229960005107 darunavir Drugs 0.000 description 2
- CJBJHOAVZSMMDJ-HEXNFIEUSA-N darunavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1[C@@H]2CCO[C@@H]2OC1)C1=CC=CC=C1 CJBJHOAVZSMMDJ-HEXNFIEUSA-N 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- IUQJDHJVPLLKFL-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetate;dimethylazanium Chemical compound CNC.OC(=O)COC1=CC=C(Cl)C=C1Cl IUQJDHJVPLLKFL-UHFFFAOYSA-N 0.000 description 1
- AEUAEICGCMSYCQ-UHFFFAOYSA-N 4-n-(7-chloroquinolin-1-ium-4-yl)-1-n,1-n-diethylpentane-1,4-diamine;dihydrogen phosphate Chemical compound OP(O)(O)=O.ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 AEUAEICGCMSYCQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010069767 H1N1 influenza Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 108010079944 Interferon-alpha2b Proteins 0.000 description 1
- KJHKTHWMRKYKJE-SUGCFTRWSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O KJHKTHWMRKYKJE-SUGCFTRWSA-N 0.000 description 1
- OFFWOVJBSQMVPI-RMLGOCCBSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O.N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 OFFWOVJBSQMVPI-RMLGOCCBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- -1 VC 0.5g Chemical compound 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960002328 chloroquine phosphate Drugs 0.000 description 1
- ZCIGNRJZKPOIKD-CQXVEOKZSA-N cobicistat Chemical compound S1C(C(C)C)=NC(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC=2C=CC=CC=2)NC(=O)OCC=2SC=NC=2)CC=2C=CC=CC=2)=C1 ZCIGNRJZKPOIKD-CQXVEOKZSA-N 0.000 description 1
- 229960002402 cobicistat Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZCGNOVWYSGBHAU-UHFFFAOYSA-N favipiravir Chemical compound NC(=O)C1=NC(F)=CNC1=O ZCGNOVWYSGBHAU-UHFFFAOYSA-N 0.000 description 1
- 229950008454 favipiravir Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004525 lopinavir Drugs 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000036997 mental performance Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960000311 ritonavir Drugs 0.000 description 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical group 0.000 description 1
- 229960003232 troxerutin Drugs 0.000 description 1
- KCFYEAOKVJSACF-UHFFFAOYSA-N umifenovir Chemical compound CN1C2=CC(Br)=C(O)C(CN(C)C)=C2C(C(=O)OCC)=C1CSC1=CC=CC=C1 KCFYEAOKVJSACF-UHFFFAOYSA-N 0.000 description 1
- 229960004626 umifenovir Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating pneumonia, and relates to application of liquorice and a compound thereof in treatment of patients with novel coronavirus infection pneumonia.
Description
Technical Field
The invention relates to the field of medicines, in particular to an antiviral traditional Chinese medicine composition for treating pneumonia.
Background
The traditional Chinese medicine liquorice has the effects of regulating the middle warmer and relieving urgency, moistening lung and detoxifying, eliminating phlegm and stopping cough, dredging channels and collaterals, promoting blood and qi circulation, harmonizing the effects of the medicines and the like, and is widely applied in the clinical field of traditional Chinese medicine. A large number of scientific researches prove that the main effective component of the liquorice is glycyrrhizic acid. The pentacyclic triterpene structure of glycyrrhizic acid is very similar to that of adrenocortical hormone, and pharmacological studies show that the glycyrrhizic acid medicament can generate adrenocortical hormone-like pharmacological action without the side effect of the adrenocortical hormone. A large number of scientific experiments show that the glyceric acid medicine has the functions of resisting virus, resisting inflammation, resisting biological oxidation and regulating immunity.
After 2003, the Dinghong professor group worked on the research of anti-inflammatory drugs to replace hormones, and after more than ten years of research, the anti-inflammatory mechanism of the 'corticoid-like substances' such as licorice extract, glycyrrhizic acid, glycyrrhetinic acid and derivatives thereof was finally anchored, and the 'corticoid-like substances' were researched and used for treating the world intractable diseases of inflammatory bowel diseases.
The dinghong professor group filed a series of inventions: 201210042289.4, the patent names: use of glycyrrhizic acid, glycyrrhetinic acid or salts thereof, gel composition and preparation method thereof; 201010535114.8, the patent names: intestine positioning preparation of glycyrrhetinic acid, glycyrrhetinic acid and salts thereof, and preparation method and application thereof; 200810047995.1, the patent names: glycyrrhizic acid, glycyrrhetinic acid or salts thereof or derivative temperature-sensitive gel thereof and a preparation method and application thereof; 200610018369.0, the patent names: application of ammonium glycyrrhetate in preparing medicine for treating inflammatory bowel disease is disclosed.
The dinghong professor team published a series of research papers: research on the action of diammonium glycyrrhizinate on rat ulcerative colitis and related mechanisms, in the journal of Chinese New medicine, 2007(24), 2027-. Protective effects of glycyrrhetic acid by reactive treatment on a TNBS-induced ratio theory model. journal of pharmacy and pharmacology, August 2, 2010.
After the epidemic situation outbreak, on the basis of the medicines prescribed in hospitals, the scheme of the diammonium glycyrrhizinate matched with vitamins and rutin is matched, about 50 cases of application information are received from 1 month 25 to 2 months 3 days, the symptom improvement time is about 1 to 5 days, the symptom complete disappearance time is 2 to 7 days, the treatment period is greatly shortened than the common treatment period of 2 to 3 weeks, in addition, the scheme has few adverse reactions and high effective rate, and because the diammonium glycyrrhizinate is a marketed medicine, the method is easy to popularize quickly, relieves the epidemic situation, saves the lives of patients and reduces the sequelae of the patients after healing, and the method is a scheme worthy of urgent research and popularization.
Disclosure of Invention
A Chinese medicinal composition for treating pneumonia comprises Glycyrrhrizae radix and pericarpium Citri Tangerinae, and can be used for treating viral infection;
a Chinese medicinal composition for treating pneumonia also contains antiviral drug.
The traditional Chinese medicine composition for treating pneumonia is characterized by comprising any one of the following components: honeysuckle, codonopsis pilosula, fritillaria, preserved plum, pinellia ternate, citrus, cowberry fruit, anise, fennel, mint, borneol, rhodiola rosea, ginger, cassia twig, black sesame, soybean, peanut, walnut, roughhaired holly root, rehmannia root, dwarf lilyturf tuber, Chinese date, donkey-hide gelatin, heartleaf houttuynia herb, indigowoad root, grape seed, American ginseng, medlar, blueberry, cowberry fruit powder, carrot, apple, pumpkin and balsam pear.
A traditional Chinese medicine composition for treating pneumonia is characterized in that: to the treatment of infections of the Coronaviridae, Filoviridae, Flaviviridae, arenaviridae, or Paramyxoviridae families; or, infection, symptom, pneumonia, respiratory infection of coronavirus, or, new type coronavirus.
A traditional Chinese medicine composition for treating pneumonia is characterized in that: preparing the medicine and the health care product.
A traditional Chinese medicine composition for treating pneumonia: the method is characterized in that: making into decoction, powder, capsule, tablet, granule, pellet, sustained release capsule, and soft capsule.
The invention relates to a traditional Chinese medicine composition for treating pneumonia, which is characterized in that: diseases related to the treatment of viral infections include, but are not limited to, avian influenza, influenza a, influenza H1N1, influenza H7N9, swine influenza, ebola, sars pneumonia, and neocoronary pneumonia.
The antiviral drug comprises any one or more of recombinant human interferon, recombinant human interferon w, recombinant human interferon α -2b, lopinavir, ritonavir, lopinavir ritonavir, darunavir, cobicistat, darunavir, arbidol, oseltamivir, ridciclovir, chloroquine phosphate, Favipiravir and Lianhua antipyretic capsules.
The invention innovates a novel treatment scheme of coronavirus pneumonia, diammonium glycyrrhizinate is taken half an hour after meals, three granules are taken once every day (1 to 3); especially, it is suggested that hypertension patients should be used with cautions, if the condition of the disease is necessary, the blood pressure can be monitored, and antihypertensive drugs are prepared; VC tablets are taken 0.5 g/day (1 to 3 times per day) half an hour after meal; the rutin tablet is taken according to the instruction. In particular, it is suggested that rutin tablets, taken 1 to 3 times per day, exert therapeutic effects in assisting VC, but some individuals cause cough, so if cough is aggravated after taking, rutin can be stopped.
Detailed Description
The applicant shall now make further details of the medical use of the present invention with reference to specific examples, in order to enable those skilled in the art to more deeply understand and appreciate the technical solutions and effects of the present invention.
The following examples should not be construed to limit the scope of the claims to the invention in any way.
Example 1:
certain patient, female, 50 years old, 19 # fever 20 # lung sheet-shaped glass-milled dense-temperature shadow, hemogram: leucopenia, lymphopenia, no disease bed, oral administration of Abidol + levofloxacin, tylenol, 38-38.8 deg.C, taking 2 tablets of tylenol to reduce to 37.5 deg.C, taking 1 tablet of tylenol, and taking 38 deg.C to 25 days, and can continuously generate heat, cough, and chest distress.
Beginning on day 25: diammonium glycyrrhizinate 9 granules/day, VC 0.5 g/day, levofloxacin; abidol and tylenol were discarded.
Day 25: 38-38.8 ℃; no change in cough;
day 26: 37.8 to 38.0 ℃; cough is unchanged, and appetite is still poor;
day 27: cough at 37.6-38.0 deg.C is improved, appetite is still, and emotion is tense;
day 28: 37.2-37.8 ℃, good appetite and easy body;
day 29: 36.8-37.0 ℃, good appetite, no sweating due to debility and good mood.
Example 2:
a certain patient is a woman in 36 years old, has No. 18 fever, is isolated at home, and purchases the medicines of the amisol, the oxitasvir and the amoxicillin by oneself until 25 days, still at 37.8-38.5 ℃, and the patient feels suffocated in chest half night, has poor appetite and can not eat a bowl of porridge.
Start to buy the drug at 10 am 25 days: diammonium glycyrrhizinate, VC 0.5g, amoxicillin and cilostavir.
The 26 th morning at 9 am for 45 minutes, the body temperature is normal 36.5 ℃, the head is not painful, the chills are not caused, the appetite is good, and a large bowl of noodles is eaten in the morning. There was still a cough. The sleep is very good. By 29 days, the stability was maintained.
Example 3:
a certain patient is a woman in the age of 36, the temperature is 37-38 ℃, the patient takes oseltamivir and levofloxacin for 5 days, the patient looks at the lung for more than two times and takes a thin tablet shape after 25 days, the tablet shape is slightly high and dense, the CRP ═ ℃,. the white blood cells are normal, the number of lymphocytes is reduced, the appetite is poor, and the patient eats a meal for one day;
beginning at 10 am on 26 days: diammonium glycyrrhizinate and VC 0.5g, and stop all other medicines;
day 27: 36.7-37.0 ℃, dizziness and poor appetite;
day 28: 36.4-36.8 ℃, cough is improved, appetite is improved, and 2 bowls of noodles are eaten in one meal;
day 29: normal, with a slight cough.
Example 4:
a certain patient is male, is 40 years old, has fever in 19 days, is isolated at home, and purchases oseltamivir, mobixacin and tenor by oneself until 25 days, still at 37.4-38.6 ℃, and is suffocated and awakened in chest half night, and poor appetite.
The medicine is taken at 10 nights of 25 days: diammonium glycyrrhizinate + VC for stopping other drugs
Day 26: 9:47, 36.2 ℃; 13:00, 36.7 ℃; 15:30, 37.0 ℃;
the body temperature is stable until 29 days, and the appetite and spirit are completely recovered
Example 5:
a certain patient starts to have fever in 1 month and 8 days after being aged 60 years, keeps 37.5-39 ℃, takes photos in 1 month and 22 days, and rubs the lung with glass and dense ℃ shadow, white blood cells ↓andlymphocytes ↓andtypical virus pneumonia characteristics. After taking oseltavir, tenor, lotus blast and Mobisfloxacin, fever is still continuous, and the chest radiography is rechecked after 5 days, which shows that the lung injury is aggravated and the cough is aggravated.
No. 27 start to take the drug: diammonium glycyrrhizinate + VC for stopping other medicines
Number 28: the cough is relieved, and the temperature is about 37.5 ℃; NO. 29 with good mental performance, about 37.5 ℃;
30 days, the body temperature returns to normal 36.8-37 DEG C
Example 6:
a certain patient is a woman in 60 years old and suffers from diseases in 26 days 1 month, low fever, diarrhea and numbness of hands and feet, cannot go to hospital for medical treatment, is isolated at home, and belongs to mild disease.
No. 27 start to take the drug: diammonium glycyrrhizinate + VC.
No. 28 diarrhea and normal body temperature
Normal in all 29-30 days
Example 7:
a certain patient is a woman who is 55 years old and suffers from the disease in 22 days 1 month, the fever continues, the sign of pulmonary virus infection cannot be reported due to the fact that the hospital is busy, the patient has no improvement in Abidol, the patient has no opportunity to take tablets for the second time, the pulmonary infection is aggravated, and the patient still has no opportunity to test blood and perform nucleic acid examination.
The diammonium glycyrrhizinate, VC and rutin are taken 10 o' clock later on 29 days, and all other medicines are stopped.
Night 29 days, body temperature 38.6 ℃;
7 o' clock on day 30, 38.0 ℃;
day 30, 11 o' clock, 37.5 ℃;
number 31, 36.4 ℃.
Example 8:
the fever lasts to 29 days after 1 month and 18 days after 50 years of age of a certain patient, diarrhea starts at 28 days, and Abidol, oseltamivir, honeysuckle antipyretic fever and tylonol are taken as raw materials
Taking diammonium glycyrrhizinate + VC + rutin at 10 o' clock later in 29 days, and stopping taking all other medicines
Body temperature recovered to 36.5 deg.C in 30 days
Example 9:
a certain patient, female, is 32 years old, has a cough at 37.2-38.0 deg.C for 6 days with low fever, and has no improvement on symptoms after using oseltamivir and mobisacin
Taking diammonium glycyrrhizinate + VC + rutin for 27 days
28 days, body temperature 37.2-37.5 deg.C
29 days, body temperature 36.8-37.1 deg.C
30 days, body temperature of 36.5-36.8 DEG C
Example 10:
the patient takes amoxicillin, diammonium glycyrrhizinate, VC and rutin for 25 days, wherein the patient is a male patient or a male patient who is 50 years old and has low fever for 5 days and cough
26 days, body temperature of 37.8-38 deg.C
27 days, body temperature 36.5-36.8 deg.C
Normal body temperature for 30 days
Example 11:
when a certain patient has fever, the diammonium glycyrrhizinate, VC and rutin are taken, the body temperature is 36.3-37 ℃ on the third day, the blood oxygen is 84-88, the appetite is good, and the cough is relieved.
Example 12:
a certain patient is a woman in 63 years old, has fever of 37.8 ℃ in 1 month and 20 days, dry cough and general soreness, is negative in flu A and B in 21 days hospital, has a prescription of oseltamivir capsules for 24 days, has fever reduction and no dry cough, but has general joint pain, has double lung infection found by CT, has a prescription of azithromycin for 25 days, has levofloxacin instilled, is taken by lotus antipyretic capsules, and has poor mental status by adding cefotaxime azithromycin for 26 days.
Day 27: taking diammonium glycyrrhizinate + VC + azithromycin
Day 28-2 month 1 day: taking diammonium glycyrrhizinate, VC and troxerutin
Day 27: poor mental state and inappetence
Day 29: good spirit and cough and headache
Day 31: except for occasional cough, other symptoms are absent,
2, month and 1 day: the mental state is well-changed and other symptoms are recovered
Example 13:
patients with certain drug, female, fever of 37.2-38.5 deg.C, taking Paracetamol and Cefach with symptoms of asthenia, soreness of waist and back, and diarrhea
Diammonium glycyrrhizinate + VC (Amazafenin and cefalotin can be used after stopping taking) for 31 days
Diammonium glycyrrhizinate plus VC are taken 31 days at 37.8 ℃ in the evening
Fever reduction in 1 day, body temperature maintained at 36 deg.C, and appetite and spirit transferred well
Example 14:
taking diammonium glycyrrhizinate + VC + rutin tablet for 3 days, the body temperature is recovered to 36.3 deg.C, and cough is relieved
Example 15:
when a certain patient has fever of 37.6 ℃, the body temperature of the patient is recovered to below 37 ℃ after taking the diammonium glycyrrhizinate, VC and rutin tablets for 2 days.
Example 16:
a traditional Chinese medicine composition (formula I) for treating pneumonia comprises 5g of liquorice and 5g of dried orange peel.
A Chinese medicinal composition for treating pneumonia is prepared from Glycyrrhrizae radix 5g and pericarpium Citri Tangerinae 5g by decocting in water.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of starch and magnesium stearate, mixing uniformly, granulating and drying. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of lactose and magnesium stearate, and the traditional Chinese medicine composition is prepared by uniformly mixing, granulating and drying. Can be used for preparing powder, tablet, and capsule.
A Chinese medicinal composition for treating pneumonia comprises Glycyrrhrizae radix 5g and pericarpium Citri Tangerinae 5g, adding appropriate amount of water, concentrating, drying, adding appropriate amount of semen glycines powder and magnesium stearate, mixing, granulating, and drying. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of black sesame powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of donkey-hide gelatin powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of peanut powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of Chinese date powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of citrus powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of tomato powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of grape seed powder and magnesium stearate, mixing uniformly, granulating and drying. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of carrot powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of medlar powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of blueberry powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A Chinese medicinal composition for treating pneumonia is prepared from Glycyrrhrizae radix 5g and pericarpium Citri Tangerinae 5g by adding appropriate amount of water, concentrating, drying, adding appropriate amount of cowberry fruit powder and magnesium stearate, mixing, granulating, and drying. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of apple powder and magnesium stearate, mixing uniformly, granulating and drying. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of pumpkin powder and magnesium stearate are added, and the mixture is uniformly mixed, granulated and dried. Can be used for preparing powder, tablet, and capsule.
A traditional Chinese medicine composition for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel, a proper amount of water, concentration, drying, a proper amount of bitter gourd powder and magnesium stearate are added, mixed uniformly, granulated and dried. Can be used for preparing powder, tablet, and capsule.
Example 17:
a traditional Chinese medicine composition (formula II) for treating pneumonia comprises 5g of liquorice, 5g of dried orange peel and 2g of honeysuckle.
The other preparations and the process are the same as the formula I.
Example 18:
a traditional Chinese medicine composition (prescription III) for treating pneumonia comprises 20g of liquorice, 30g of dried orange peel and 10g of mint.
The other preparations and the process are the same as the formula I.
Example 19:
a traditional Chinese medicine composition (prescription four) for treating pneumonia comprises 20g of liquorice, 30g of dried orange peel and 30g of preserved plum.
The other preparations and the process are the same as the formula I.
Example 20:
a traditional Chinese medicine composition for treating pneumonia (prescription five), comprises 20g of liquorice, 30g of dried orange peel, 30g of preserved plum and 10g of mint.
The other preparations and the process are the same as the formula I.
Example 21:
a traditional Chinese medicine composition for treating pneumonia (prescription six), 20g of liquorice, 30g of dried orange peel, 30g of roughhaired holly root and 10g of mint.
The other preparations and the process are the same as the formula I.
Example 22:
a traditional Chinese medicine composition (prescription seven) for treating pneumonia comprises 20g of liquorice, 30g of dried orange peel, 30g of roughhaired holly root and 10g of rhodiola rosea.
The other preparations and the process are the same as the formula I.
Example 22:
a Chinese medicinal composition for treating pneumonia comprises Glycyrrhrizae radix 20g, pericarpium Citri Tangerinae 30g, flos Ilicis Asprellae 30g, and herba Houttuyniae 10 g.
The other preparations and the process are the same as the formula I.
Example 23:
a traditional Chinese medicine composition for treating pneumonia (formula nine), comprises 20g of liquorice, 30g of dried orange peel and 10g of houttuynia cordata.
The other preparations and the process are the same as the formula I.
Example 24:
a Chinese medicinal composition for treating pneumonia comprises Glycyrrhrizae radix 20g, pericarpium Citri Tangerinae 30g, and fructus Foeniculi 10 g.
The other preparations and the process are the same as the formula I.
Example 25:
a traditional Chinese medicine composition (prescription eleven) for treating pneumonia comprises 20g of liquorice, 30g of dried orange peel and 10g of cassia twig.
The other preparations and the process are the same as the formula I.
Example 26:
a Chinese medicinal composition for treating pneumonia comprises Glycyrrhrizae radix 20g, pericarpium Citri Tangerinae 30g, and rhizoma Zingiberis recens 10 g.
The other preparations and the process are the same as the formula I.
Example 27:
a traditional Chinese medicine composition for treating pneumonia (prescription thirteen), liquorice 20g, dried orange peel 30g and radix codonopsitis 10 g.
The other preparations and the process are the same as the formula I.
Example 28:
a Chinese medicinal composition for treating pneumonia (prescription fourteen), licorice 20g, dried orange peel 30g, American ginseng 10 g.
The other preparations and the process are the same as the formula I.
Example 29:
a Chinese medicinal composition for treating pneumonia (prescription fifteen), Glycyrrhrizae radix 20g, pericarpium Citri Tangerinae 30g, and Ginseng radix 10 g.
The other preparations and the process are the same as the formula I.
Example 30:
a Chinese medicinal composition for treating pneumonia comprises radix Glycyrrhizae 20g, pericarpium Citri Reticulatae 30g, and fructus Anisi Stellati 10 g.
The other preparations and the process are the same as the formula I.
Claims (6)
1. A Chinese medicinal composition for treating pneumonia is characterized by comprising a formula of liquorice and dried orange peel, and is used for treating viral infection.
2. The traditional Chinese medicine composition for treating pneumonia according to claim 1, characterized by further comprising an antiviral drug.
3. The traditional Chinese medicine composition for treating pneumonia according to any one of claims 1-2, characterized by comprising any one of the following components: the traditional Chinese medicine composition for treating pneumonia is characterized by comprising any one of the following components: honeysuckle, codonopsis pilosula, fritillaria, preserved plum, pinellia ternate, citrus, cowberry fruit, anise, fennel, mint, borneol, rhodiola rosea, ginger, cassia twig, black sesame, soybean, peanut, walnut, roughhaired holly root, rehmannia root, dwarf lilyturf tuber, Chinese date, donkey-hide gelatin, heartleaf houttuynia herb, indigowoad root, grape seed, American ginseng, medlar, blueberry, cowberry fruit powder, carrot, apple, pumpkin and balsam pear.
4. A Chinese medicinal composition for the treatment of pneumonia according to any one of claims 1-3, which is characterized by: to the treatment of infections of the Coronaviridae, Filoviridae, Flaviviridae, arenaviridae, or Paramyxoviridae families; or, infection, symptoms, pneumonia of coronavirus, or, a novel coronavirus.
5. The Chinese medicinal composition for treating pneumonia according to any one of claims 1-4, which is characterized in that: preparing the medicine and the health care product.
6. The Chinese medicinal composition for treating pneumonia according to any one of claims 1-4: the method is characterized in that: making into decoction, powder, capsule, tablet, granule, pellet, sustained release capsule, and soft capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010094608.0A CN111281914A (en) | 2020-02-16 | 2020-02-16 | Traditional Chinese medicine composition for treating pneumonia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010094608.0A CN111281914A (en) | 2020-02-16 | 2020-02-16 | Traditional Chinese medicine composition for treating pneumonia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111281914A true CN111281914A (en) | 2020-06-16 |
Family
ID=71024547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010094608.0A Pending CN111281914A (en) | 2020-02-16 | 2020-02-16 | Traditional Chinese medicine composition for treating pneumonia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111281914A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111939211A (en) * | 2020-07-17 | 2020-11-17 | 深圳市老年医学研究所 | Traditional Chinese medicine composition for adjuvant therapy of middle-stage neocoronary infection and preparation method thereof |
| CN113785926A (en) * | 2021-09-17 | 2021-12-14 | 兰州丰洋新材料科技有限公司 | Plant beverage with multiple functions of health care, protection and prevention of infectious diseases |
| WO2021259772A1 (en) * | 2020-06-26 | 2021-12-30 | Evonik Operations Gmbh | Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by coronaviridae |
| WO2022043738A1 (en) * | 2020-08-29 | 2022-03-03 | Portillo Rosado Rosa Maria | Pharmaceutical composition containing a surfactant and natural plant extracts for preventing and treating coronavirus |
| CN116617342A (en) * | 2023-01-18 | 2023-08-22 | 渤海大学 | Preparation method of atomization spray for armyworm virus infection |
-
2020
- 2020-02-16 CN CN202010094608.0A patent/CN111281914A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021259772A1 (en) * | 2020-06-26 | 2021-12-30 | Evonik Operations Gmbh | Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by coronaviridae |
| CN111939211A (en) * | 2020-07-17 | 2020-11-17 | 深圳市老年医学研究所 | Traditional Chinese medicine composition for adjuvant therapy of middle-stage neocoronary infection and preparation method thereof |
| WO2022043738A1 (en) * | 2020-08-29 | 2022-03-03 | Portillo Rosado Rosa Maria | Pharmaceutical composition containing a surfactant and natural plant extracts for preventing and treating coronavirus |
| CN113785926A (en) * | 2021-09-17 | 2021-12-14 | 兰州丰洋新材料科技有限公司 | Plant beverage with multiple functions of health care, protection and prevention of infectious diseases |
| CN116617342A (en) * | 2023-01-18 | 2023-08-22 | 渤海大学 | Preparation method of atomization spray for armyworm virus infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111281914A (en) | Traditional Chinese medicine composition for treating pneumonia | |
| CN109674958B (en) | Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof | |
| CN111388582A (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof | |
| CN111214550A (en) | New application of medicine in treating or preventing novel coronavirus pneumonia 2019-nCoV | |
| CN103285119A (en) | Chinese medicine composition for treating autoimmune liver disease, and preparation method thereof | |
| CN103656403A (en) | Traditional Chinese medicine composition for treating phthisis and preparation method of traditional Chinese medicine composition | |
| CN102258726A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN111184762A (en) | Solid preparation for cocktail therapy | |
| CN111714553A (en) | A Chinese medicinal composition for treating new coronary pneumonia and/or influenza, and its preparation method | |
| CN103495048A (en) | Traditional Chinese medicine composition for treating children's aphthous stomatitis | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN101480412A (en) | Honeybee four-treasure for treating prostatosis | |
| CN111450201B (en) | Composition for improving acute mastitis and/or regulating breast function of puerpera | |
| CN100457144C (en) | Compound capsule of Chinese date kernel, and preparation method | |
| CN111265563A (en) | Cocktail therapy dosing regimen | |
| CN1075386C (en) | Method for producing Anruneixiao medicinal liquid | |
| CN111588793A (en) | A Chinese medicinal composition, its preparation method, and its application in preparing medicine or health product for treating male oligospermia and asthenospermia | |
| CN111228355A (en) | Traditional Chinese medicine composition for treating heart and lung diseases, preparation method thereof and clinical preparation | |
| CN1326548C (en) | Medicine for treating gonorrhoea | |
| CN100457177C (en) | Chinese medicinal health-care preparation for cloaring lung, supplementing kidney | |
| CN101670046A (en) | Chinese medicinal composition for gastritis and esophagitis and preparation process thereof | |
| CN106309901A (en) | Radix scrophulariae buccal tablets and preparation method thereof | |
| CN111346168A (en) | Medicine for treating oral ulcer and preparation method thereof | |
| CN1318042C (en) | Application of barbat skullcap in preparing medication for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200616 |